HealthTab™ provides a complete, turnkey solution underpinning national pharmacy-based PoCT networks, including best-in-class instruments, consumables, onboarding, training, and ongoing support for ...

Looking to go beyond the usual blockbusters and find inventive, small-but-mighty science-fiction films with striking ideas, ...

Abbott secured FDA approval for its CardioMEMS heart failure system features.The company reported annual revenue of $44.33B with net profit of $6.52B.Analysts issued Buy ratings with an average price ...

ALPHA | Overview of Technology◾️What is SciTech at Abbott LaboratoriesA suite of technologies to measure, judge, and ...

Abbott is kickstarting the U.S. commercial launch of SimpleScreen CRC, an FDA-approved blood-based (CRC) screening test for ...

Abbott has commercially rolled out SimpleScreen CRC in the US, introducing a blood test approved by the Food and Drug Administration (FDA) for colorectal cancer screening. Freenom ...

The SimpleScreen CRC blood test, developed by Freenome, will be sold exclusively by Abbott alongside its Cologuard Plus home ...

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal ...

The last 12 months at Abbott Laboratories (NYSE:ABT) has been defined by a bold bet that put at risk the reputation it has carried for decades as a medtech ...

When validated with human samples, the device performed as well as a reverse transcription polymerase chain reaction, or RT-PCR, test, considered the gold standard of diagnostic testing for ...

Abbott Laboratories will pay $385 million to settle allegation related to how it operated a manufacturing plant tied to contaminated powdered baby formula suspected of causing infant deaths.

Abbott Laboratories has agreed to pay more than $384 million to settle allegations that it knowingly manufactured infant formula in environments that posed a substantial risk of contamination, then ...